Clinical trials: Ligneous Conjunctivitis

Ligneous Conjunctivitis

Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients

• Completed
• Age: All ages
• Phase 2/3
• Results posted

Kedrion Human Plasminogen, a sterile human plasma-derived plasminogen preparation for topical ocular use will be evaluated for the indication of treatment of ligneous conjunctivitis.

Trial name

NCT01554956

Testing

Human Plasminogen

Where

3 sites in United States, Italy

Volunteers

12 people

Sponsor

Kedrion S.p.A.